Drug Profile
Research programme: LCAT stimulants - Amgen
Alternative Names: LCAT activators - Amgen; Lecithin cholesterol acyltransferase activators - Amgen; Phosphatidylcholine sterol O acyltransferase stimulants - Amgen; Pyrazine analogues as LCAT activators - AmgenLatest Information Update: 15 Sep 2016
Price :
$50
*
At a glance
- Originator Amgen
- Class Pyrazines; Small molecules
- Mechanism of Action Enzyme stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atherosclerosis; Coronary disorders
Most Recent Events
- 15 Sep 2016 Discontinued - Preclinical for Atherosclerosis in USA (unspecified route) (Amgen pipeline; September 2016)
- 15 Sep 2016 Discontinued - Preclinical for Coronary disorders in USA (unspecified route) (Amgen pipeline; September 2016)
- 10 Apr 2008 Preclinical trials in Atherosclerosis in USA (unspecified route)